Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cédric Turpinat

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersGermain Busto, Cédric Turpinat, Sophie Navucet, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2025
Impact of preanalytical delay on the performance of plasma Aβ42, Aβ42/40, p-tau217, and p-tau217/Aβ42 in detecting brain amyloidosis in the ALZAN cohortConstance Delaby, Audrey Gabelle, Marie Duchiron, et al.
Ebiomedicine|June 13, 2025
Comparative performance of plasma pTau181/Aβ42, pTau217/Aβ42 ratios, and individual measurements in detecting brain amyloidosisSylvain Lehmann, Audrey Gabelle, Marie Duchiron, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
The ratio of plasma pTau217 to Aβ42 outperforms individual measurements in detecting brain amyloidosisSylvain Lehmann, Audrey Gabelle, Marie Duchiron, et al.
Neurology|April 14, 2026
Influence of Decreased Kidney Function on Plasma Biomarkers of Neurodegenerative Disorders in Routine Care: Confirmation of the Interest of RatiosEtienne Mondésert, Jean-Paul Cristol, Anne-Sophie Bargnoux, et al.
Stroke|May 12, 2025
Delay in Carotid Web Diagnosis Remains Common and Associated With an Increased Risk of Stroke RecurrencePauline Poirette, Nicolas Chausson, Jean Papaxanthos, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 28, 2024
Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screeningGaël Nicolas, Aline Zaréa, Morgane Lacour, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersGermain Busto, Cédric Turpinat, Sophie Navucet, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2025
Impact of preanalytical delay on the performance of plasma Aβ42, Aβ42/40, p-tau217, and p-tau217/Aβ42 in detecting brain amyloidosis in the ALZAN cohortConstance Delaby, Audrey Gabelle, Marie Duchiron, et al.
Ebiomedicine|June 13, 2025
Comparative performance of plasma pTau181/Aβ42, pTau217/Aβ42 ratios, and individual measurements in detecting brain amyloidosisSylvain Lehmann, Audrey Gabelle, Marie Duchiron, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
The ratio of plasma pTau217 to Aβ42 outperforms individual measurements in detecting brain amyloidosisSylvain Lehmann, Audrey Gabelle, Marie Duchiron, et al.
Neurology|April 14, 2026
Influence of Decreased Kidney Function on Plasma Biomarkers of Neurodegenerative Disorders in Routine Care: Confirmation of the Interest of RatiosEtienne Mondésert, Jean-Paul Cristol, Anne-Sophie Bargnoux, et al.
Stroke|May 12, 2025
Delay in Carotid Web Diagnosis Remains Common and Associated With an Increased Risk of Stroke RecurrencePauline Poirette, Nicolas Chausson, Jean Papaxanthos, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 28, 2024
Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screeningGaël Nicolas, Aline Zaréa, Morgane Lacour, et al.
Pageof 1